Comments
Unichem Laboratories has entered into a settlement pact with pharma major Eli Lilly & Company and ICOS Corporation for resolving their patent litigation regarding generic tadalafil used for treating erectile dysfunction. Under the agreement, Unichem expects to launch its generic tadalafil product in the US on or not before March 26, 2019 under certain circumstances. It, however, did not provide any details about the ‘certain circumstances’.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.